NGFR and neoplasm: Dichotomization of the patient cohort based on the median of the percentage of CD271high tumor cells (median: 63.2%) did not show statistically significant differences with regard to response (p=0.260) or survival for patients with a high fraction of CD271 positive cells (see Figure 4).